DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Bradeen HA, Eide CA, O'Hare T et al.
Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.
Blood 2006;
108: 2332-2338
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.